ECSP003607A - PHARMACEUTICAL FORMULATIONS IN HYDROXYPROPYLMETILCELLULOSE CAPSULES - Google Patents
PHARMACEUTICAL FORMULATIONS IN HYDROXYPROPYLMETILCELLULOSE CAPSULESInfo
- Publication number
- ECSP003607A ECSP003607A ECSP003607A ECSP003607A EC SP003607 A ECSP003607 A EC SP003607A EC SP003607 A ECSP003607 A EC SP003607A EC SP003607 A ECSP003607 A EC SP003607A
- Authority
- EC
- Ecuador
- Prior art keywords
- hydroxypropylmetilcellulose
- capsules
- pharmaceutical formulations
- formulations
- solubilized
- Prior art date
Links
- 239000002775 capsule Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical class C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Una formulación farmacéutica oral que comprende, en una cápsula de hidroxipropilmetilcelulosa, un análogo de camptotecina dispersado o solubilizado en una matriz semi-sólida. Estas formulaciones son útiles para el tratamiento de enfermedades neoplásticas.An oral pharmaceutical formulation comprising, in a hydroxypropyl methylcellulose capsule, a camptothecin analog dispersed or solubilized in a semi-solid matrix. These formulations are useful for the treatment of neoplastic diseases.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003607 ECSP003607A (en) | 2000-08-07 | 2000-08-07 | PHARMACEUTICAL FORMULATIONS IN HYDROXYPROPYLMETILCELLULOSE CAPSULES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003607 ECSP003607A (en) | 2000-08-07 | 2000-08-07 | PHARMACEUTICAL FORMULATIONS IN HYDROXYPROPYLMETILCELLULOSE CAPSULES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003607A true ECSP003607A (en) | 2000-09-22 |
Family
ID=42041214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003607 ECSP003607A (en) | 2000-08-07 | 2000-08-07 | PHARMACEUTICAL FORMULATIONS IN HYDROXYPROPYLMETILCELLULOSE CAPSULES |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003607A (en) |
-
2000
- 2000-08-07 EC ECSP003607 patent/ECSP003607A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR025060A1 (en) | PHARMACEUTICAL FORMULATIONS IN HYDROXYPROPILMETILCELLULOSE CAPSULES | |
| EE9900288A (en) | Use of an Oral Pharmaceutical Composition for the manufacture of a medicament for the treatment of erectile dysfunction in men | |
| ECSP083351A (en) | PHARMACEUTICAL COMPOSITIONS | |
| AP1954A (en) | Controlled release compositions comprising nimesulide. | |
| UY27455A1 (en) | DERIVATIVES N- (1,4,5,6-TETRAHIDRO-CICLOPENTAPIRAZOL -3-IL) - REPLACED. ITS OBTAINING AND USE AS DRUGS. | |
| AR026610A1 (en) | A PIRROLIDINACETAMIDE DERIVATIVE ONLY OR IN COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | |
| PA8575701A1 (en) | ACID INSULIN PREPARATIONS WITH IMPROVED STABILITY | |
| ATE309798T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING CANNABIDIOL DERIVATIVES | |
| AR032293A1 (en) | PHARMACEUTICAL CASE | |
| AR023806A1 (en) | USE OF A PEPTIDE MIXTURE FOR THE MANUFACTURE OF A THERAPEUTIC AGENT FOR PROFILAXIS AND / OR CANCER TREATMENT, PHARMACEUTICAL COMPOSITIONS AND VACCINES CONTAINING SUCH MIXTURE AND THE PROCEDURES FOR PREPARATION OF THESE COMPOSITIONS | |
| UY25544A1 (en) | NEFAZODONE DOSAGE FORM | |
| AR034517A1 (en) | PHARMACEUTICAL FORMULATION | |
| DE60102590T2 (en) | PHARMACEUTICAL FORMS FOR THE TREATMENT OF ORAL MYCOSES | |
| AR028448A1 (en) | FORMULATIONS CONTAINING A GLUCOCORTICOID DRUG FOR THE TREATMENT OF BRONCOPULMONARY DISEASES | |
| AR021086A1 (en) | OMEGA-AMIDAS OF N-ARILSULFONIL-AMINO ACIDS, A PROCEDURE FOR THE PREPARATION, MEDICATION, USE OF SUCH COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT AND PROCEDURE FOR THE PREPARATION OF A MEDICINAL PRODUCT. | |
| AR034142A1 (en) | A PHARMACEUTICAL COMPOSITION, METHOD FOR MANUFACTURING A MEDICINAL BASED ON SUCH COMPOSITION AND USE OF THE COMPOSITION | |
| UY26171A1 (en) | PHARMACEUTICAL FORMULATION AND METHOD FOR THE TREATMENT OF LATE APPEARANCE DYSKINESIA | |
| CO4970832A1 (en) | NEW FORMULATIONS AND PROCESSES FOR ITS MANUFACTURE | |
| PL368686A1 (en) | Novel aminobenzoephenones | |
| ECSP003607A (en) | PHARMACEUTICAL FORMULATIONS IN HYDROXYPROPYLMETILCELLULOSE CAPSULES | |
| DE60214476D1 (en) | Pharmaceutical preparations containing active ingredients which are suitable for unauthorized administration | |
| MY141008A (en) | Oral formulations of deoxypeganine and their uses | |
| AR027677A1 (en) | A THERAPEUTIC PHARMACEUTICAL COMPOSITION THAT INCLUDES CAMPTOTECHINE AND CYCLOFOSPHAMIDE FOR THE TREATMENT OF CANCER | |
| DK1499278T3 (en) | Pharmaceutical dosage form exhibiting immediate release comprising polymorphic tibolone | |
| DE60235549D1 (en) | PHARMACEUTICAL FORMULATION AND LIGANDS INCLUDING THEREOF; UEA-1 MIMETICA |